FCX vs VRDN · P/E 38, rev $13.26B vs rev $425.0K
Freeport-McMoran Copper & Gold Inc (FCX) versus Viridian Therapeutics Inc (VRDN) — a side-by-side from cached financials, not a winner call.
Freeport-McMoran Copper & Gold Inc (FCX) is a copper company listed on US.
Viridian Therapeutics Inc (VRDN) is a biotechnology company listed on US.
Latest reported FCX revenue for 2026-06-30 was $13.26B. Net income was $1.86B. FCX currently screens at market cap $67.80B and trailing P/E 38.0.
Latest reported VRDN revenue for 2026-06-30 was $425.0K. Net income was -$232.0M. VRDN currently screens at market cap $1.39B.
FCX currently screens at market cap $67.80B and trailing P/E 38.0. VRDN currently screens at market cap $1.39B.
Not investment advice. Open the FCX and VRDN stock pages for the full models.
Not investment advice.